πŸ‡ΊπŸ‡Έ FDA
Patent

US 12146004

Polymyxin compounds and uses thereof

granted A61KA61K38/00A61K38/12

Quick answer

US patent 12146004 (Polymyxin compounds and uses thereof) held by SPERO THERAPEUTICS, INC. expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SPERO THERAPEUTICS, INC.
Grant date
Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K38/00, A61K38/12, A61P, A61P31/04